Literature DB >> 24172703

Recurrent epistaxis in children.

Gerald W McGarry1.   

Abstract

INTRODUCTION: Up to 9% of children may have recurrent nosebleeds, usually originating from the anterior septum, but the majority grow out of the problem. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for recurrent idiopathic epistaxis in children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 5 systematic reviews or RCTs that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiseptic cream (containing chlorhexidine hydrochloride, neomycin sulfate, or both), petroleum jelly, and silver nitrate cautery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24172703      PMCID: PMC3812896     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  7 in total

1.  A prospective, single-blind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood.

Authors:  H Kubba; C MacAndie; M Botma; J Robison; M O'Donnell; G Robertson; N Geddes
Journal:  Clin Otolaryngol Allied Sci       Date:  2001-12

Review 2.  Interventions for recurrent idiopathic epistaxis (nosebleeds) in children.

Authors:  Ali Qureishi; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Management of epistaxis in children.

Authors:  J Ruddy; D W Proops; K Pearman; H Ruddy
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1991-04       Impact factor: 1.675

4.  A prospective, single-blind, randomized controlled trial of petroleum jelly/Vaseline for recurrent paediatric epistaxis.

Authors:  S Loughran; E Spinou; W A Clement; R Cathcart; H Kubba; N K Geddes
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-06

5.  A double-blind randomized controlled trial of management of recurrent nosebleeds in children.

Authors:  Nicholas Calder; Swee Kang; Lyndsay Fraser; Tash Kunanandam; Jennifer Montgomery; Haytham Kubba
Journal:  Otolaryngol Head Neck Surg       Date:  2009-03-17       Impact factor: 3.497

6.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

7.  Long-term effectiveness of antiseptic cream for recurrent epistaxis in childhood: five-year follow up of a randomised, controlled trial.

Authors:  S Robertson; H Kubba
Journal:  J Laryngol Otol       Date:  2008-02-11       Impact factor: 1.469

  7 in total
  5 in total

1. 

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-06       Impact factor: 3.275

2.  Epistaxis in a Pediatric Outpatient Clinic: Could It be an Alarming Sign?

Authors:  Mohsen Saleh ElAlfy; Azaa Abdel Gawad Tantawy; Badr Eldin Mostafa Badr Eldin; Mohamed Amin Mekawy; Yasmeen Abd elAziz Mohammad; Fatma Soliman Elsayed Ebeid
Journal:  Int Arch Otorhinolaryngol       Date:  2021-06-03

3.  Recurrent epistaxis in children.

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-06       Impact factor: 3.275

4.  Epistaxis as a Common Presenting Symptom of Glanzmann's Thrombasthenia, a Rare Qualitative Platelet Disorder: Illustrative Case Examples.

Authors:  Michael Recht; Meera Chitlur; Derek Lam; Syana Sarnaik; Madhvi Rajpurkar; David L Cooper; Sriya Gunawardena
Journal:  Case Rep Emerg Med       Date:  2017-02-19

5.  Recurrent Epistaxis and Unilateral Intranasal Mass in A Teenager.

Authors:  Brad Bradshaw; Seckin O Ulualp; Veena Rajaram; Christopher Liu
Journal:  Am J Case Rep       Date:  2021-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.